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– Physics, University of Cambridge) in 1997 appears to 
continue to hold ground: ‘Simple-minded analysis may suggest 
that water, being a fluid, cannot have a structure of the kind 
that such a picture would demand. But cases such as that of 
liquid crystals, which while flowing like an ordinary fluid can 
maintain an ordered structure over macroscopic distances, 
show the limitations of such ways of thinking. There have 
not, to the best of my knowledge, been any refutations of 
homoeopathy that remain valid after this particular point is 
taken into account.’
   Perhaps then, the only end that can and should be sought 
is the end of poorly substantiated conclusions resulting in 
unnecessary worldwide sensationalism.
   For the complete HSA response visit www.hsa.org.za
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   Bridget Farham replies: Predictably enough those who 
practise homeopathy have responded both to my summary1 
of the article on homeopathy in the Lancet and to the Lancet 
themselves. While those who use homeopathy in their practice 
have every right to do so, as long as it doesn’t compromise 
patient care, I feel compelled to answer some of the points 
in their response that serve only to emphasise just how 
unscientific their approach is.
   The first and most important point is the complaint that the 
Lancet article was based on only 8 trials of homeopathy. The 
whole point of the analysis was to try to tease out whether 
or not the effects of homeopathy can be ascribed more to the 
placebo effect than to a specific effect. In order to do this, 
the authors of the Lancet article could only use certain types 
of trials that met the rigorous criteria demanded of fully 
randomised, placebo-controlled trials – that left only 8 trials of 
homeopathic medication. The authors took bias into account, 
for both trials of conventional medicine and homeopathic 
medicine. That is precisely what makes the analysis so 
scientifically rigorous.
   The comments by others in the homeopathic field serve only 
further to emphasise the lack of a scientific approach. Studies 
of the effect of penicillin should be designed precisely to 
ignore the preconceived idea that penicillin has an intrinsically 
beneficial nature. That is how scientific hypothesis should 
work. I am not qualified to comment on the comments made 
by materials scientists. But I would still, on the basis of a 
rigorous scientific training (not obtained during my medical 
degree, I hasten to add), question whether changes that are too 
small to detect can have a clinical effect in the human body. 
What a scientist tries to avoid is the idea encapsulated in the 
phrase, ‘if I hadn’t believed it, I wouldn’t have seen it.’
1. Farham B. The start of reason (Forum). S Afr Med J 2005; 95: 764.
Dangers of DDT
To the Editor: Your comments on the use of DDT and 
Rachel Carson’s book Silent Spring in a recent issue of the 
Journal1 cannot go unchallenged. Carson’s book highlighted 
a phenomenon that had been troubling environmentalists, 
namely the decline in a number of species, particularly some 
bird species. 
   The implication that the only organisms affected by 
DDT were the mosquito and possibly ‘certain species of 
aquatic invertebrates’ is fatuous. This is documented by the 
effectiveness of DDT in combating agricultural pests across 
a number of families, such as the codling moth, cotton boll 
weevil and corn borer. In 1959, 35 771 tons of DDT were used 
in the USA.2 Such a volume would inevitably have had a 
profound effect on a number of food chains. Anecdotally, I 
visited the Okavango Delta during the tsetse fly eradication 
campaign involving use of Dieldrin (a related compound). 
A notable feature of the trip was the masses of fish floating 
belly up, interspersed with a fair number of birds of different 
species. There is nothing specific about the action of DDT on 
mosquitoes.
   Granted some of the claims may have been exaggerated, but 
there is fieldwork backed by laboratory studies to substantiate 
the toxicity of DDT and its metabolites on a number of 
species. In addition, a novel and unexpected effect on eggshell 
thickness has been demonstrated. This had the effect of birds 
laying fragile eggs, easily damaged and resulting in a high 
mortality among the chicks. This was particularly pronounced 
in species such as birds of prey at the top of a food chain.3 The 
decline in a number of species has been attributed in part to 
this effect. The fact that some species have shown an increase 
in numbers following the ban on DDT could be taken as 
further evidence for this effect. 
   Although the evidence for carcinogenicity among humans 
is not conclusive there are good experimental data to show a 
carcinogenic effect in both rodents and non-human primates.2,4 
There is concern that DDT and its metabolites could have an 
effect on reproduction and pregnancy.4
  Contrary to the comments in your Editor’s Choice1 a recent 
review2 concluded that there was sufficient evidence of 
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environmental damage and experimental evidence suggesting 
a carcinogenic effect in non-human primates to warrant 
continuation of the ban, and that alternatives should be 
urgently sought. 
   Attitudes to DDT have changed and it is no longer sprayed 
indiscriminately into the environment. Despite limiting its use 
to indoors, concerns remain. A review in the Lancet4 concluded 
that ’indoor spraying will unavoidably expose women to 
amounts of DDT that are associated with forms of toxic effects 
that might increase infant mortality’. To blandly state that it is 
quite innocuous to humans is to ignore the evidence.
   Finally, to assume that the dramatic decline in malaria 
cases, as described by Marahaj et al.,5 is entirely due to the 
reintroduction of DDT should be viewed cautiously. Rainfall 
patterns have a significant effect on malaria and 2000 was a 
singularly wet year, as noted by the authors. 
   Your comments do not add to the topic, which needs to be 
debated and not shrugged off with a glib comment.
Dave Whitelaw
Department of Medicine
Stellenbosch University and  
Tygerberg Hospital
Tygerberg, W Cape
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Concurrent use of clopidogrel  
(Plavix) and atorvasatin (Lipitor) is 
contraindicated
To the Editor: After a recent discussion with two family 
physicians in Lenasia, south of Johannesburg, it has come to 
our attention that it is common practice for cardiologists in 
the area to prescribe both clopidogrel (Plavix) and atorvasatin 
(Lipitor) simultaneously after a coronary event. Clopidogrel 
induces irreversible alterations of the platelet adenosine 
diphosphate (ADP) receptor P2Y12 mediating inhibition of 
stimulated adrenal cyclase activity by ADP.1 Permanent 
modification of the platelet ADP receptor by thienopyridines is 
consistent with time-dependent, cumulative inhibition of ADP-
induced platelet aggression upon repeated daily dosing with 
ticlopidine or clopidogrel and with slow recovery of platelet 
aggression function after drug withdrawal.2 
Clopidogrel is a prodrug, requiring hepatic metabolism by 
cytochrome P450 isoform 3A4 in order to generate the active 
metabolite, a transient intermediate that covalently modifies 
and inactivates the receptor.3
When clopidogrel and atorvasatin, a CYP3A4 substrate, 
are present at equimolar concentrations in vitro, clopidogrel 
metabolism is inhibited by more than 90%.3 Three separate 
studies4-6 suggest that concurrent treatment with lipophilic 
strains that are substrates of CYP3A4 (e.g. atorvasatin and 
simvastatin) may interfere with the inhibitory effects of 
clopidogrel on platelet function. In the study by Lau et al.5 
atorvasatin, but not pravastatin, attenuated the antiplatelet 
effect of clopidogrel in a dose-dependent manner.
It would therefore seem that the concomitant use of 
atorvasatin and clopidogrel is contraindicated.7
We welcome comments from cardiologists and the drug 
companies (Pfizer and Sanofi-Synthelabo).
N Chetty
N H Naran
Platelet Research Unit 
National Health Laboratory Service/
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Emergency medicine
To the Editor: Congratulations on two counts to those involved 
in the advancement of emergency medicine in South Africa.
   First and foremost for the establishment of emergency 
medicine as a separate specialist discipline.1
   Secondly (and perhaps somewhat pedantically) for adhering 
to the correct terminology. In the USA there is a tendency 
to interchange the term ‘emergency’, meaning sudden, 
urgent, usually unexpected occurrence or occasion requiring 
immediate action,2 with the term ‘emergent’.
    The primary meaning of the word ‘emergent’ relates to 
its derivation from ‘emerge’, meaning coming into view or 
notice or rising from a liquid or other surrounding medium.2 
Use of the term emergent to replace emergency represents a 
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